In this episode of Don’t Call Me Resilient, Prof. Cheryl Thompson untangles the history of hair relaxers for Black women—and the health risks and lawsuits now linked to them
Study shows an increased risk of breast cancer recurrence in postmenopausal patients with obesity and HR+ early-stage breast cancer treated with aromatase inhibitors.